{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:04:59Z","timestamp":1793912699376,"version":"4.8.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020619","name":"Faculty of Veterinary Science, Chulalongkorn University","doi-asserted-by":"publisher","award":["390252002"],"award-info":[{"award-number":["390252002"]}],"id":[{"id":"10.13039\/501100020619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.lfs.2023.121929","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T11:19:30Z","timestamp":1688987970000},"page":"121929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Vericiguat preserved cardiac function and mitochondrial quality in a rat model of mitral regurgitation"],"prefix":"10.1016","volume":"328","author":[{"given":"Peeraya","family":"Jungtanasomboon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surunchana","family":"Nussaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hathaichanok","family":"Winwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patcharapol","family":"Suebthawinkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pakit","family":"Boonpala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van Nhut Khanh","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakkawee","family":"Saengklub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarawut","family":"Kumphune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowalak","family":"Panyasing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusak","family":"Kijtawornrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.lfs.2023.121929_bb0005","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1080\/14656566.2021.1937121","article-title":"Vericiguat for the treatment of heart failure: mechanism of action and pharmacological properties compared with other emerging therapeutic options","volume":"22","author":"Hulot","year":"2021","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.lfs.2023.121929_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.665797","article-title":"New targets in heart failure drug therapy","volume":"8","author":"Correale","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"20","key":"10.1016\/j.lfs.2023.121929_bb0015","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.lfs.2023.121929_bb0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jchf.2017.08.013","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of the efficacy and safety of the oral soluble guanylate cyclase stimulator: the VICTORIA trial","volume":"6","author":"Armstrong","year":"2018","journal-title":"JACC Heart Fail."},{"issue":"5","key":"10.1016\/j.lfs.2023.121929_bb0025","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.005998","article-title":"Rationale and design of the VITALITY-HFpEF trial","volume":"12","author":"Butler","year":"2019","journal-title":"Circ. Heart Fail."},{"issue":"15","key":"10.1016\/j.lfs.2023.121929_bb0030","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/eurheartj\/ehw593","article-title":"Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study","volume":"38","author":"Pieske","year":"2017","journal-title":"Eur. Heart J."},{"issue":"14","key":"10.1016\/j.lfs.2023.121929_bb0035","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s40265-021-01586-y","article-title":"Drug treatment of heart failure with reduced ejection fraction: defining the role of vericiguat","volume":"81","author":"Coats","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2023.121929_bb0040","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.2741\/2122","article-title":"Nitric oxide and mitochondria","volume":"12","author":"Brown","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.lfs.2023.121929_bb0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.niox.2019.04.005","article-title":"The effect of nitric oxide on mitochondrial respiration","volume":"88","author":"Poderoso","year":"2019","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.lfs.2023.121929_bb0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/pr.115.011502","article-title":"Mitochondrial quality control as a therapeutic target","volume":"68","author":"Suliman","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.lfs.2023.121929_bb0055","doi-asserted-by":"crossref","first-page":"H962","DOI":"10.1152\/ajpheart.00832.2015","article-title":"Sirt3 protects mitochondrial DNA damage and blocks the development of doxorubicin-induced cardiomyopathy in mice","volume":"310","author":"Pillai","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121929_bb0060","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1002\/jcp.26335","article-title":"Simple kinetic model of mitochondrial swelling in cardiac cells","volume":"233","author":"Chapa-Dubocq","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.lfs.2023.121929_bb0065","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI120849","article-title":"Mitochondrial dysfunction in pathophysiology of heart failure","volume":"128","author":"Zhou","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.lfs.2023.121929_bb0070","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/FJC.0000000000000817","article-title":"Targets of cGMP\/cGKI in cardiac myocytes","volume":"75","author":"Adler","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"11","key":"10.1016\/j.lfs.2023.121929_bb0075","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/CIRCULATIONAHA.111.065300","article-title":"Long-term effects of sildenafil in a rat model of chronic mitral regurgitation: benefits of ventricular remodeling and exercise capacity","volume":"125","author":"Kim","year":"2012","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.lfs.2023.121929_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9081047","article-title":"Soluble guanylate cyclase stimulator vericiguat enhances long-term memory in rats without altering cerebral blood volume","volume":"9","author":"Nelissen","year":"2021","journal-title":"Biomedicines"},{"issue":"13","key":"10.1016\/j.lfs.2023.121929_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015640","article-title":"Sacubitril\/valsartan improves cardiac function and decreases myocardial fibrosis via downregulation of exosomal miR-181a in a rodent chronic myocardial infarction model","volume":"9","author":"Vaskova","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.lfs.2023.121929_bb0090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.mito.2011.01.008","article-title":"Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria","volume":"11","author":"Thummasorn","year":"2011","journal-title":"Mitochondrion"},{"issue":"41","key":"10.1016\/j.lfs.2023.121929_bb0095","doi-asserted-by":"crossref","first-page":"38152","DOI":"10.1074\/jbc.M101980200","article-title":"15-Deoxy-Delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors","volume":"276","author":"Li","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.lfs.2023.121929_bb0100","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3109\/13880209.2015.1014569","article-title":"Inhibition of p38 MAPK activation protects cardiac mitochondria from ischemia\/reperfusion injury","volume":"53","author":"Kumphune","year":"2015","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.lfs.2023.121929_bb0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-4939-9420-5_8","article-title":"The role and study of mitochondrial impairment and oxidative stress in cholestasis","volume":"1981","author":"Heidari","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.lfs.2023.121929_bb0110","doi-asserted-by":"crossref","first-page":"H1727","DOI":"10.1152\/ajpheart.00882.2008","article-title":"Impact of mitral regurgitation on left ventricular anatomic and molecular remodeling and systolic function: implication for outcome","volume":"296","author":"Pu","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"10","key":"10.1016\/j.lfs.2023.121929_bb0115","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4070\/kcj.2011.41.10.603","article-title":"Survival, exercise capacity, and left ventricular remodeling in a rat model of chronic mitral regurgitation: serial echocardiography and pressure-volume analysis","volume":"41","author":"Kim","year":"2011","journal-title":"Korean Circ. J."},{"issue":"7","key":"10.1016\/j.lfs.2023.121929_bb0120","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019274","article-title":"Dapagliflozin improves cardiac hemodynamics and mitigates arrhythmogenesis in mitral regurgitation-induced myocardial dysfunction","volume":"10","author":"Lin","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.lfs.2023.121929_bb0125","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jcmg.2018.01.009","article-title":"Mitral valve regurgitation in the contemporary era: insights into diagnosis, management, and future directions","volume":"11","author":"El Sabbagh","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"4","key":"10.1016\/j.lfs.2023.121929_bb0130","first-page":"20","article-title":"Doxorubicin cardiotoxicity in the rat: an in vivo characterization","volume":"46","author":"Hayward","year":"2007","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.121929_bb0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.46582\/jsrm.0501006","article-title":"Establishment of a rat model of myocardial infarction with a high survival rate: a suitable model for evaluation of efficacy of stem cell therapy","volume":"5","author":"Srikanth","year":"2009","journal-title":"J. Stem Cells Regen. Med."},{"issue":"9","key":"10.1016\/j.lfs.2023.121929_bb0140","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1089\/ars.2012.4824","article-title":"Nitric oxide synthases in heart failure","volume":"18","author":"Carnicer","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.lfs.2023.121929_bb0145","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCRESAHA.107.164798","article-title":"Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase-deficient mice","volume":"102","author":"Zhang","year":"2008","journal-title":"Circ. Res."},{"issue":"Pt 2","key":"10.1016\/j.lfs.2023.121929_bb0150","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1113\/jphysiol.2001.014126","article-title":"Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes","volume":"540","author":"Layland","year":"2002","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121929_bb0155","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.yjmcc.2009.03.021","article-title":"Phosphodiesterase 5 restricts NOS3\/soluble guanylate cyclase signaling to L-type Ca2+ current in cardiac myocytes","volume":"47","author":"Wang","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.lfs.2023.121929_bb0160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10741-012-9323-1","article-title":"Soluble guanylate cyclase: a potential therapeutic target for heart failure","volume":"18","author":"Gheorghiade","year":"2013","journal-title":"Heart Fail. Rev."},{"issue":"22","key":"10.1016\/j.lfs.2023.121929_bb0165","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1093\/eurheartj\/ehq396","article-title":"Is oxidative stress a therapeutic target in cardiovascular disease?","volume":"31","author":"Munzel","year":"2010","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.lfs.2023.121929_bb0170","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1124\/jpet.117.247429","article-title":"Pharmacological characterization of IW-1973, a novel soluble guanylate cyclase stimulator with extensive tissue distribution, antihypertensive, anti-inflammatory, and antifibrotic effects in preclinical models of disease","volume":"365","author":"Tobin","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"22","key":"10.1016\/j.lfs.2023.121929_bb0175","doi-asserted-by":"crossref","first-page":"11057","DOI":"10.1073\/pnas.1821045116","article-title":"sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH","volume":"116","author":"Hall","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.lfs.2023.121929_bb0180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.56808\/2985-1130.2463","article-title":"Indices of myocardial contractility","volume":"43","author":"Kijtawornrat","year":"2013","journal-title":"Thai J. Vet. Med."},{"issue":"2","key":"10.1016\/j.lfs.2023.121929_bb0185","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/toxsci\/kft244","article-title":"Test of the usefulness of a paradigm to identify potential cardiovascular liabilities of four test articles with varying pharmacological properties in anesthetized guinea pigs","volume":"137","author":"Kijtawornrat","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"6 Pt 2","key":"10.1016\/j.lfs.2023.121929_bb0190","first-page":"H1218","article-title":"Contractility-dependent curvilinearity of end-systolic pressure-volume relations","volume":"252","author":"Burkhoff","year":"1987","journal-title":"Am. J. Phys."},{"issue":"12","key":"10.1016\/j.lfs.2023.121929_bb0195","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1161\/ATVBAHA.107.151167","article-title":"Nitric oxide and mitochondrial signaling: from physiology to pathophysiology","volume":"27","author":"Erusalimsky","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121929_bb0200","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.tem.2009.04.001","article-title":"Mitochondrial generation of free radicals and hypoxic signaling","volume":"20","author":"Poyton","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.lfs.2023.121929_bb0205","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrm762","article-title":"Does nitric oxide modulate mitochondrial energy generation and apoptosis?","volume":"3","author":"Moncada","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3\u20134","key":"10.1016\/j.lfs.2023.121929_bb0210","first-page":"411","article-title":"Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis","volume":"383","author":"Boyd","year":"2002","journal-title":"Biol. Chem."},{"issue":"8","key":"10.1016\/j.lfs.2023.121929_bb0215","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/sj.cdd.4401261","article-title":"Nitric oxide: NO apoptosis or turning it ON?","volume":"10","author":"Brune","year":"2003","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.lfs.2023.121929_bb0220","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1006\/bbrc.2001.4670","article-title":"Nitric oxide as a bioregulator of apoptosis","volume":"282","author":"Chung","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523005647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523005647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:05:13Z","timestamp":1762211113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523005647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":44,"alternative-id":["S0024320523005647"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121929","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vericiguat preserved cardiac function and mitochondrial quality in a rat model of mitral regurgitation","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121929","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121929"}}